Sales of oxycodone by doctors fall in Florida
February 2, 2012 By Scott Hiaasen in Medications
The number of oxycodone pills sold by Florida doctors dropped dramatically in 2011, following a series of high-profile arrests and a legislative crackdown on the storefront "pill mills" that made South Florida the hub of a nationwide black market in prescription painkillers.
According to the U.S. Drug Enforcement Administration, sales of oxycodone from doctors' offices and pain clinics dropped 97 percent from 2010 to 2011. Florida doctors sold almost 46 million oxycodone tablets in 2010, but only 1.2 million pills were sold by doctors last year, the DEA data shows.
The biggest reason for the drop: New legislation passed last year that largely prevents doctors from dispensing oxycodone and other narcotics from their offices. The state law, which took effect July 1, was aimed at hobbling storefront pain clinics, where doctors commonly sold drugs directly to walk-in patients paying only in cash. Many of these "patients" were really drug couriers from Kentucky, West Virginia, Tennessee and other states, investigators say.
Oxycodone has become the leading cause of drug overdoses in Florida, contributing to more than 1,500 deaths in 2010, records show.
Over the past year, the DEA also has increased the pressure on pain clinics with a series of undercover investigations leading to indictments of dozens of doctors and clinic owners around the state. Many more doctors have been forced to surrender their DEA licenses to write prescriptions.
In 2010, 90 of the top 100 oxycodone-prescribing doctors in the United States were from Florida. But last year, only 13 Florida doctors were listed among the top 100 prescribers - and none from Florida were in the top 10.
At the same time, oxycodone sales were increasing among doctors in Kentucky, Georgia and Tennessee, the DEA found.
Pain-clinic doctors may still write prescriptions that can be filled at pharmacies under Florida's new law. But oxycodone sales from Florida pharmacies have dropped as well, by 14 percent from 2010 to 2011, the DEA data shows.
One large pharmacy chain, CVS, announced in December that it would not honor prescriptions for painkillers from some Florida doctors out of concern the pills could get diverted to the black market.Â
In recent months, the DEA has also focused its attention on rogue pharmacies, some of which have been working in concert with suspect pain clinics.Â
In October, for example, the feds filed drug-trafficking charges against the owner of the Robert's Drug Store pharmacy located in the Stephen P. Clark Government Center, the hub of Miami-Dade county government.
Last month, Daniel and Francine Sweet, the owners of the Focus on Health pharmacy in Plantation, Fla., pleaded guilty to money-laundering charges as part of a scheme to fill phony prescriptions for Miami-based drug dealers, court records show. The pharmacy ordered more than 1 million oxycodone pills in a one-year period, prosecutors said. The Sweets are scheduled to be sentenced in March.
"The arrests and administrative actions taken against the owner of pill mills and rogue pharmacies, and the doctors and pharmacists working there, not only put these individuals out of business, but sent a clear message to others that the diversion of illicit pharmaceutical painkillers would not be tolerated," Mark Trouville, the special agent in charge of the DEA's Miami field office, said in a statement.
State officials recently launched a new tool to try to curb illegal painkiller sales and prevent "doctor shopping" by patients who go to multiple doctors seeking pills. In September, the Florida Department of Health launched a new prescription drug monitoring database that allows doctors and pharmacists - and, in some cases, criminal investigators - to track a patient's prescription history to weed out doctor shopping.
The database now contains data on 26 million prescriptions dating back to December 2010, according to a Brandeis University study of the program.
(c)2012 The Miami Herald
Distributed by MCT Information Services
-
US aims at its deadliest drug problem: painkillers
Apr 20, 2011 |
not rated yet |
0
-
Deaths from painkiller overdose triple in decade
Nov 01, 2011 |
not rated yet |
0
-
Deaths related to narcotic pain relievers have doubled since 1991: Study
Dec 07, 2009 |
not rated yet |
0
-
Senator warns FDA on danger of newest painkillers
Jan 08, 2012 |
not rated yet |
0
-
Harmful patterns of painkiller prescriptions seen among methadone patients
Nov 28, 2011 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Why is zone 1 in liver more prone to ischemic injury?
May 23, 2013
-
How can there be villous adenoma in colon, if there are no villi there
May 22, 2013
-
How can there be a term called "intestinal metaplasia" of stomach
May 21, 2013
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
- More from Physics Forums - Medical Sciences
More news stories
Feds fight morning-after pill age ruling in NY
(AP)—Department of Justice lawyers have again asked a federal appeals court in New York to delay lifting age restrictions and prescription requirements on an emergency contraceptive popularly known as the morning-after ...
Medications
13 hours ago |
not rated yet |
0
Merck ends development of Parkinson's disease drug
(AP)—Merck & Co. says it is ending development of an experimental Parkinson's disease drug because the drug wasn't working.
Medications
May 23, 2013 |
1 / 5 (1) |
0
J&J expects 10-plus new drug applications by 2017
(AP)—Johnson & Johnson is developing what could eventually be game-changing treatments for depression and pain, and it's aiming to apply for approval of more than 10 new medicines by 2017, executives said Thursday during ...
Medications
May 23, 2013 |
5 / 5 (1) |
0
Experts favor US approval of Merck sleeping pill (Update)
An independent panel of experts on Wednesday recommended US approval of a new Merck sleeping pill called suvorexant, but expressed concerns over the highest dosage and risks of drowsy daytime driving.
Medications
May 22, 2013 |
not rated yet |
0
Glaxo, US partnering to develop new antibiotics
GlaxoSmithKline PLC says it's starting an unusual collaboration with the U.S. government to develop several antibiotics for both bioterrorism threats and bacterial infections resistant to current medicines.
Medications
May 22, 2013 |
not rated yet |
0
First drug to improve heart failure mortality in over a decade
Coenzyme Q10 decreases all cause mortality by half, according to the results of a multicentre randomised double blind trial presented today at Heart Failure 2013 congress. It is the first drug to improve heart failure mortality ...
Seniors more likely to crash when driving with pet, study finds
(HealthDay)—Animals make great companions for senior citizens, but elderly people who always drive with a pet in the car are far more likely to crash than those who never drive with a pet, researchers have ...
Heart failure accelerates male 'menopause'
Heart failure accelerates the aging process and brings on early andropausal syndrome (AS), according to research presented today at the Heart Failure Congress 2013. AS, also referred to as male 'menopause', was four times ...
Death highest in heart failure patients admitted in January, on Friday, and overnight
Mortality and length of stay are highest in heart failure patients admitted in January, on Friday, and overnight, according to research presented today at the Heart Failure Congress 2013. The analysis of nearly 1 million ...
New immune system discovered
(Medical Xpress)—A research team, led by Jeremy Barr, a biology post-doctoral fellow, unveils a new immune system that protects humans and animals from infection.
Brain can be trained in compassion, study shows
Until now, little was scientifically known about the human potential to cultivate compassion—the emotional state of caring for people who are suffering in a way that motivates altruistic behavior.